A novel solid-in-oil nanosuspension for transdermal delivery of diclofenac sodium

Pharmaceutical Research

Volumn 25, Issue 4, 2008, Pages 896-901

  Piao, Hongyu ^a   Kamiya, Noriho ^a   Hirata, Akihiko ^b   Fujii, Takeru ^b   Goto, Masahiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b ASPION Corporation   (Japan)

Author keywords

Diclofenac sodium; Isopropyl myristate; Solid in oil nanosuspension; Sucrose ester; Transdermal delivery; Yucatan micropig skin

Indexed keywords

DICLOFENAC; MYRISTIC ACID ISOPROPYL ESTER; SUCROSE ERUCATE; SURFACTANT; WATER OIL CREAM;

ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; MALE; MINIPIG; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SKIN CULTURE; SKIN PENETRATION; SOLID IN OIL NANOSUSPENSION; SUSPENSION;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMISTRY, PHARMACEUTICAL; DICLOFENAC; DRUG CARRIERS; DRUG COMPOUNDING; MYRISTATES; NANOSTRUCTURES; PARTICLE SIZE; PERMEABILITY; SKIN; SKIN ABSORPTION; SUCROSE; SURFACE-ACTIVE AGENTS; SWINE; SWINE, MINIATURE; VISCOSITY; WATER;

EID: 43349108297     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-007-9445-7     Document Type: Article

References (17)

1. E. C. Ku, J. M. Wasvary, and W. D. Cash. Diclofenac sodium (GP 45840, Voltaren), a potent inhibitor of prostaglandin synthetase. Biochem. Pharmacol. 24:641-643 (1975).
2. C. Sakamoto. NSAIDs caused gastric mucosal injury: with a special reference to COX-2. J. Nippon Med. Sch. 70:5-11 (2003).
3. R. Grahame. Transdermal non-steroidal anti-inflammatory agents. Br. J. Clin. Pract. 49:33-35 (1995).
4. G. L. Flynn and B. Stewart. Percutaneous drug penetration: choosing candidates for transdermal development. Drug Dev. Res. 13:169-185 (1988).
5. M. Müller, H. Mascher, C. Kikuta, S. schäfer, M. Brunner, G. Dorner, and H. G. Eichler. Diclofenac concentrations in defined tissue layers after topical administration. Clin. Pharmacol. Ther. 62:292-299 (1997).
6. A. Arellano, S. Santoyo, C. Martin, and P. Ygartua. Enhancing of terpenes on the in vitro percutaneous absorption of diclofenac sodium. Int. J. Pharm. 130:141-145 (1996).
7. A. Arellano, S. Santoyo, C. Martin, and P. Ygartua. Influence of propylene glycol and isopropyl myristate on the in vitro percutaneous penetration of diclofenac sodium from carbopol gels. Eur. J. Pharm. Sci. 7:129-135 (1998).
8. S. Naito and H. Tominaga. Percutaneous absorption of diclofenac sodium ointment. Int. J. Pharm. 24:115-124 (1985).
9. R. R. Boinpally, S. L. Zhou, S. Poondru, G. Devraj, and B. R. Jasti. Lecithin vesicles for topical delivery of diclofenac. Eur. J. Pharm. Biopharm. 56:389-392 (2003).
10. E. Escribano, A. C. Calpena, J. Queralt, R. Obach, and J. Domenech. Assessment of diclofenac permeation with different formulations: anti-inflammatory study of a selected formula. Eur. J. Pharm. Sci. 19:203-210 (2003).
11. F. Dreher, P. Walde, P. Walther, and E. Wehrli. Interaction of a lecithin microemulsion gel with human Stratum corneum and its effect on transdermal transport. J. Control. Release. 45:131-140 (1997).
12. K. Takahashi, H. Sakano, N. Numata, S. Kuroda, and N. Mizuno. Effect of fatty acid diesters on permeation of Anti-inflammatory drugs through rat skin. Drug Dev. Ind. Pharm. 10:1285-1294 (2002).
13. H. Piao, N. Kamiya, J. Watanabe, H. Yokoyama, A. Hirata, T. Fuijii, I. Shimizu, S. Ito, and M. Goto. Oral delivery of diclofenac sodium using a novel solid-in-oil suspension. Int. J. Pharm. 313:159-162 (2006).
14. C. S. Leopold and B. C. Lippold. An attempt of the penetration enhancing effects of lipophilic vesicles with differential scanning calorimetry (DSC). J. Pharm. Pharmacol. 47:276-281 (1995).
15. P. Karande, A. Jain, K. Ergun, V. Kispersky, and S. Mitragotri. Design Principles of chemical penetration enhancers for transdermal drug delivery. Proc. Natl. Acad. Sci. USA 102:4688-4693 (2005).
16. M. E. Roberts and K. R. Mueller. Comparisons of in vitro nitroglycerin (TNG) flux across Yucatan pig, Hairless mouse, and Human skins. Pharm. Res. 7:673-676 (1990).
17. L. B. Lopes, J. H. Collett, M. Vitoria, and L. B. Bently. Topical delivery of cyclosporin A: an in vitro study using monoolein as a penetration enhancer. Eur. J. Pharm. Biopharm. 60:25-30 (2005).